Autopsy report · NCT00171925

Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I

“Recruitment in study could not be reached after 8 yrs of recruiting”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 years 1 month after it had already started.
• Ran for about 8 years 3 months before it stopped.
• 143 participants enrolled.
• Results were posted on the registry 2 years 5 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Novartis Pharmaceuticals

Sponsor type

Industry

Conditions

Multiple Myeloma Stage I

Interventions

Zoledronic acid; Calcium / Vitamin D

Participants

143

Sites

1

Countries

Germany

Trials that died the same way

• TubeClear® Evaluation in Pediatric Patients (Phase I)
  “Unable to recruit; study determined not feasible to continue” (81% match in meaning)
• Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic Sclerosis
  “Study terminated early due to difficulties in subject recruitment” (78% match in meaning)
• Early Versus Late Amniotomy Following EAB Cervical Ripening
  “Study was terminated due to difficulties in recruitment” (78% match in meaning)
• A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal
  “Unable to meet the study's recruitment goals” (78% match in meaning)
• Influence of Dexmedetomidine or Propofol on ICU Delirium
  “insufficient recruitment over a long period” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.